Kymera Therapeutics (KYMR) Capital Expenditures (2019 - 2026)
Kymera Therapeutics (KYMR) posted Capital Expenditures of $473,000 for Q2 2026, down 31.9% from $695,000 a year earlier but up 9.0% from the prior quarter.
Kymera Therapeutics (KYMR) Capital Expenditures (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Kymera Therapeutics was $1.19 million, down 37.5% year-over-year; for FY2025, it came in at $1.45 million, down 88.7% from FY2024.
- Annual Capital Expenditures shows a five-year compound annual growth rate of -30.7% (FY2020 to FY2025).
- In prior years, Kymera Therapeutics' Capital Expenditures was $12.84 million in FY2024 (-62.8%), $34.48 million in FY2023, $2.84 million in FY2022 (+77.6%) and $1.6 million in FY2021 (-82.4%).
- Quarterly Capital Expenditures has run from a low of -$189,000 in Q3 2024 to a high of $11.63 million in Q4 2023 over five years.
- On a year-over-year basis, Capital Expenditures has declined in each of the last three quarters, with an average decline of 66.4% over the last six quarters.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q1 2023, with growth of 731.7%; the weakest was Q1 2025, with a decline of 93.7%.
- According to Business Quant data, Capital Expenditures for the three prior quarters was $434,000 (Q1 2026), $106,000 (Q4 2025) and $181,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -3.30 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 573.00 Mn |
| 10 | Kymera Therapeutics | 11.66 Bn | 8.50 Bn | - | 315,000.00 |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 315,000.00 |
| Jun 30, 2026 | 473,000.00 |
| Mar 31, 2026 | 434,000.00 |
| Dec 31, 2025 | 106,000.00 |
| Sep 30, 2025 | 181,000.00 |
| Jun 30, 2025 | 695,000.00 |
| Mar 31, 2025 | 467,000.00 |
| Dec 31, 2024 | 936,000.00 |
| Sep 30, 2024 | -189,000.00 |
| Jun 30, 2024 | 4.69 Mn |
| Mar 31, 2024 | 7.40 Mn |
| Dec 31, 2023 | 11.63 Mn |
| Sep 30, 2023 | 8.08 Mn |
| Jun 30, 2023 | 10.77 Mn |
| Mar 31, 2023 | 4.01 Mn |
| Dec 31, 2022 | 373,000.00 |
| Sep 30, 2022 | 1.25 Mn |
| Jun 30, 2022 | 735,000.00 |
| Mar 31, 2022 | 482,000.00 |
| Dec 31, 2021 | 501,000.00 |
Kymera Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=KYMR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();